Catalyst Pharmaceuticals, Inc. Provides Revenue Guidance for the Fourth Quarter and Year of 2021
February 07, 2022 at 04:50 pm EST
Catalyst Pharmaceuticals, Inc. provided revenue guidance for the fourth quarter and year of 2021. Fourth quarter 2021 total revenues are estimated to be approximately $38 million, compared to total revenues of approximately $31 million in the fourth quarter of 2020, representing an increase of approximately 24% year-over-year.
Full year 2021 total revenues are estimated to be approximately $141 million, compared to total revenues of $119 million for 2020, representing an increase of approximately 18% year-over-year.